PMVP Summary

  1. NASDAQ
  2. >
  3. PMVP
TickerPMVP
DescriptionPMV PHARMACEUTICALS INC
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees44
Next Earnings DateAugust 12th, 2022
IV360.866279%
IV Percentile99th
IV Rank100.00%
IV Skew54.576355
IV Skew Percentile94th
IV Skew SentimentBearish
Option Volume2,311
Volume1,053,262
Price$14.22
Previous Close$14.03
52-Week High$37.3199
52-Week Low$11.44
50-Day Moving Avg.$16.41
200-Day Moving Avg.$19.14
10-Day Avg. Volume1,099,852
20-Day Avg. Volume1,141,150
30-Day Avg. Volume1,115,249
3-Month Avg. Volume917,627
EPS-$1.43
Outstanding Shares45,574,075
Market Capitalization$625,276,300
CurrencyUSD
UpdatedMay 21st, 2022